Literature DB >> 9754912

Anxiolytic-like action of neurokinin substance P administered systemically or into the nucleus basalis magnocellularis region.

R U Hasenöhrl1, O Jentjens, M A De Souza Silva, C Tomaz, J P Huston.   

Abstract

There is evidence that the neurokinin substance P plays a role in neural mechanisms governing learning and reinforcement. Reinforcing and memory-promoting effects of substance P were found after it was injected into several parts of the brain and intraperitoneally. With regard to the close link between anxiety and memory processes for negative reinforcement learning, the aim of the present study was to gauge the effect of substance P on anxiety-related behaviors in the rat elevated plus-maze and social interaction test. Substance P was tested at injection sites where the neurokinin has been shown to promote learning and to serve as a reinforcer, namely in the periphery (after i.p. administration) and after injection into the nucleus basalis magnocellularis region. When administered i.p., substance P had a biphasic dose-response effect on behavior in the plus-maze with an anxiolytic-like action at 50 microg/kg and an anxiogenic-like one at 500 microg/kg. After unilateral microinjection into the nucleus basalis magnocellularis region, substance P (1 ng) was found to exert anxiolytic-like effects, because substance P-treated rats spent more time on the open arms of the plus-maze and showed an increase in time spent in social interaction. Furthermore, the anxiolytic effects of intrabasalis substance P were sequence-specific since injection of a compound with the inverse amino acid sequence of substance P (0.1 to 100 ng) did not influence anxiety parameters. These results show that substance P has anxiolytic-like properties in addition to its known promnestic and reinforcing effects, supporting the hypothesis of a close relationship between anxiety, memory and reinforcement processes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9754912     DOI: 10.1016/s0014-2999(98)00441-5

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  8 in total

Review 1.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  The Impact of Morphine on Reproductive Activity in Male Rats Is Regulated by Rf-Amid-Related Peptide-3 and Substance P Adjusting Hypothalamic Kisspeptin Expression.

Authors:  Parastoo Rahdar; Homayoun Khazali; Abdolkarim Hosseini; Amin Raeisi
Journal:  J Mol Neurosci       Date:  2019-07-09       Impact factor: 3.444

3.  Deficits in substance P mRNA levels in the CeA are inversely associated with alcohol-motivated responding.

Authors:  Andrew Rong Song Tzeng Yang; Heon Soo Yi; Jacek Mamczarz; Harry L June; Bang H Hwang; Harry L June
Journal:  Synapse       Date:  2009-11       Impact factor: 2.562

4.  Evaluation of the anxiolytic-like effect of NKP608, a NK1-receptor antagonist, in two rat strains that differ in anxiety-related behaviors.

Authors:  Leandro F Vendruscolo; Reinaldo N Takahashi; Gustavo R Brüske; André Ramos
Journal:  Psychopharmacology (Berl)       Date:  2003-08-12       Impact factor: 4.530

Review 5.  Neuronal pathways linking substance P to drug addiction and stress.

Authors:  K G Commons
Journal:  Brain Res       Date:  2009-11-11       Impact factor: 3.252

6.  Substance P enhances neuronal area and epithelial cell proliferation after colon denervation in rats.

Authors:  Nilza C Buttow; Sérgio Zucoloto; Enilza M Espreafico; Patricia Gama; Eliana P Alvares
Journal:  Dig Dis Sci       Date:  2003-10       Impact factor: 3.199

7.  Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test.

Authors:  André Rex; Jörg-Peter Voigt; Christina Gustedt; Simon Beckett; Heidrun Fink
Journal:  Psychopharmacology (Berl)       Date:  2004-05-28       Impact factor: 4.530

8.  The role of substance P in depression: therapeutic implications.

Authors:  Markus J Schwarz; Manfred Ackenheil
Journal:  Dialogues Clin Neurosci       Date:  2002-03       Impact factor: 5.986

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.